March 9, 2026, boosted by a Bloomberg report that Novo Nordisk plans to sell its obesity drugs through Hims & Hers Health (NYSE: HIMS)'s telemedicine platform, HIMS stock surged over 44% in pre-market trading. This potential partnership marks a dramatic turnaround in the patent lawsuit filed by Novo Nordisk in February. Following the news, HIMS stock rose from the previous day's closing price of $15.88 to approximately $23.12. Analysts believe this deal could help alleviate the significant legal and regulatory risks facing the stock.

🚨 Crude Oil Above $110: Is This the Start of a New Energy Supercycle? A Trader’s Perspective
#GateFebruaryTransparencyReport $BTC $ETH
The global energy market has once again captured the attention of traders and investors worldwide. In a dramatic overnight rally, crude oil prices surged sharply, pushing WTI above $110 and Brent crude beyond $110, levels that immediately reignited discussions about supply shocks, geopolitical tensions, and the possibility of a longer-term energy bull market.
For many traders, this move was not just another headline—it was a moment that highlighted how quickl